Research into the microbiome—the indigenous microbial communities (microbiota) and the
host environment that they inhabit—has changed clinicians' ideas about microbes in human …

Fecal microbiota transplantation (FMT) has become a research focus of biomedicine and
clinical medicine in recent years. The clinical response from FMT for different diseases …

Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium
difficile infection. Promising findings suggest that FMT may play a role also in the …

In the last three decades, Clostridium difficile infection (CDI) has increased in incidence and
severity in many countries worldwide. The increase in CDI incidence has been particularly …

Gut dysbiosis has been associated with inflammatory bowel disease (IBD), one of the most
common gastrointestinal diseases. The microbial communities play essential roles in host …

Objectives Although systematic evaluation has confirmed the efficacy of fresh fecal
microbiota transplantation (FMT) for treatment of recurrent and/or refractory and/or relapse …

Clostridioides difficile infection (CDI) remains a significant clinical challenge both in the
management of severe and severe-complicated disease and the prevention of recurrence …

Fecal microbiota transplantation (FMT) is an accepted procedure for the management of
recurrent Clostridioides difficile infections. FMT is generally considered safe and well …

The human gut microbiota comprises of a complex and diverse array of microorganisms,
and over the years the interaction between human diseases and the gut microbiota has …

Background Faecal microbiota transplantation or transfer (FMT) aims at replacing or
reinforcing the gut microbiota of a patient with the microbiota from a healthy donor. Not many …